Human telomeres are protected by shelterin, a complex that includes the POT1 single-stranded DNA binding protein. We found that mouse telomeres contain two POT1 paralogs, POT1a and POT1b, and we used conditional deletion to determine their function. Double-knockout cells showed that POT1a/b are required to prevent a DNA damage signal at chromosome ends, endoreduplication, and senescence. In contrast, POT1a/b were largely dispensable for repression of telomere fusions. Single knockouts and complementation experiments revealed that POT1a and POT1b have distinct functions. POT1a, but not POT1b, was required to repress a DNA damage signal at telomeres. Conversely, POT1b, but not POT1a, had the ability to regulate the amount of single-stranded DNA at the telomere terminus. We conclude that mouse telomeres require two distinct POT1 proteins whereas human telomeres have one. Such divergence is unprecedented in mammalian chromosome biology and has implications for modeling human telomere biology in mice.
INTRODUCTION
Genome integrity in mammals requires shelterin, a protein complex that associates with the telomeric TTAGGG repeat array, regulates telomere length, and protects chromosome ends (reviewed in (de Lange, 2005) ). Shelterin contains two DNA binding factors, TRF1 and TRF2, which anchor the complex along the double-stranded telomeric repeat array and recruit the shelterin components TIN2, TPP1 and Rap1. The sixth partner in shelterin is the single-stranded TTAGGG repeat binding protein, POT1, which associates with telomeres through its interaction with TPP1. Shelterin is ubiquitous and abundant at telomeres throughout the cell cycle. TRF1, TRF2, TIN2, and Rap1 are essential in the mouse ( (Celli and de Lange, 2005; Chiang et al., 2004; Karlseder et al., 2003) ; T.d.L. and M. van Overbeek, unpublished data) . Here, we describe the phenotype of POT1-deficient mouse cells.
The protective function of shelterin and the fate of dysfunctional telomeres has been deduced from the phenotypes associated with deletion of mouse TRF2 and inhibition of human TRF2 with a dominant-negative allele (Celli and de Lange, 2005; van Steensel et al., 1998) . When TRF2 is compromised, telomeres are recognized as sites of DNA damage and processed as if they represent double-strand breaks. DNA damage response factors accumulate at chromosome ends, and the ATM kinase signaling pathway is activated, leading to cell cycle arrest and apoptosis or senescence (Celli and de Lange, 2005; d'Adda di Fagagna et al., 2003; Karlseder et al., 1999; Takai et al., 2003) . The dysfunctional telomeres become a substrate for the nonhomologous end-joining (NHEJ) pathway by which DNA ligase IV joins most of the chromosome ends, creating long trains of fused chromosomes (Celli and de Lange, 2005; Smogorzewska et al., 2002; van Steensel et al., 1998) . The single-stranded telomeric overhang is attacked by an NHEJ-dependent processing step, whereas the rest of the telomeric DNA appears to remain intact, leading to the presence of TTAGGG repeats at the sites of chromosome-end fusion (Celli and de Lange, 2005; Zhu et al., 2003) .
A model has been proposed for the repression of NHEJ at mammalian telomeres (Griffith et al., 1999; de Lange, 2005) . This model is based on the observation that mammalian telomeres can occur in an altered configuration, the t-loop, in which the 3 0 telomeric overhang is strandinvaded into the duplex part of the telomeres (de Lange, 2005; Griffith et al., 1999) . Since the NHEJ pathway relies on the loading of the Ku70/80 heterodimer on free DNA ends, t-loops could block NHEJ from accessing the chromosome end. The speculation is that loss of TRF2 results in opening of the t-loop, thus exposing the chromosome ends to Ku70/80 and enabling NHEJ. TRF2 has been implicated in the formation of t-loops based on its ability to generate similar structures in model substrates in vitro (Stansel et al., 2001) . However, the role of TRF2 in t-loop formation in vivo has not been tested. It is also not known whether the t-loop configuration occurs at all telomeres and persists throughout the cell cycle.
POT1 was discovered based on its sequence similarity to proteins from hypotrichous ciliates that bind to the short single-stranded protrusion of the abundant chromosome ends in their macronuclei (Baumann and Cech, 2001 ). These ciliate telomere terminus factors recognize the sequence of the telomeric overhang in the context of a 3 0 end. Structural analysis of the Oxytricha telomeric protein (TEBPa/b) showed that the complex hides the 3 0 terminus in a deep hydrophobic protein pocket, a configuration that is thought to protect telomeres from inappropriate attack by nucleases (Horvath et al., 1998) . In agreement with this proposal, the fission yeast ortholog of TEBPa, POT1, is required for the protection of telomeres from rapid degradation (Baumann and Cech, 2001 ). The structure of its DNA binding domain showed that human POT1 might position the 3 0 terminus of its 5 0 -TTAGGGTTAG-3 0 binding site in a protein pocket, leading to the proposal that the protection of mammalian telomeres largely depends on POT1 (Lei et al., 2004) . According to this model, the telomere deprotection phenotype of TRF2 À/À cells could be due to loss of POT1, since POT1 loading is in part dependent on TRF2 (Loayza and de Lange, 2003) . The prediction of this model is that POT1 deficiency will generate a telomere deprotection phenotype similar to the phenotype of TRF2 loss. In order to address the phenotype of POT1 deficiency, we and others have used RNAi and overexpression of human POT1 mutant alleles that do not bind single-stranded DNA (Hockemeyer et al., 2005; Liu et al., 2004; Loayza and de Lange, 2003; Veldman et al., 2004; Yang et al., 2005; Ye et al., 2004) . In both settings, telomere length became deregulated, leading to excessive addition of telomeric repeats by telomerase Loayza and de Lange, 2003; Ye et al., 2004) . POT1 depletion also changed the structure of the telomere terminus (Hockemeyer et al., 2005) . The amount of single-stranded telomeric DNA was diminished and the 5 0 telomere end was altered from its precise [CCCAAT]nC-5 0 sequence to a random position. Knockdown of POT1 also resulted in a DNA damage response but the response was transient, unlike the phenotype of TRF2 loss, and did not cause cell cycle arrest in immortalized cells (Hockemeyer et al., 2005) . Furthermore, POT1 knockdown failed to elicit the severe telomere fusion phenotype observed upon inhibition of TRF2. However, as these experiments involve a partial (<10-fold) reduction of POT1, the exact role of POT1 in telomere protection remained to be determined. Here, we use gene targeting in the mouse to address the function of mammalian POT1.
RESULTS

Two Distinct POT1 Proteins at Mouse Telomeres
The human genome contains only one gene with significant homology to the ciliate telomere terminus proteins (Baumann and Cech, 2001) , and a single POT1 gene is present in the primate, dog, and cow genomes ( Figures  1A, 1B , and Figure S1A in the Supplemental Data available with this article online). In contrast, we identified two POT1 orthologs (POT1a and POT1b) in the mouse and rat genomes ( Figures 1A and 1B) . Mouse POT1a and POT1b show 71%-75% amino acid identity to human POT1 and to each other ( Figures S1B and S1C) . The mouse POT1a locus on chromosome 6 is syntenic with the human POT1 locus on chromosome 7; POT1b is located on mouse chromosome 17. The most likely origin of the two rodent POT1 genes is a recent gene duplication (Figure 1B) . Both POT1 mRNAs are represented in the EST databases (POT1a: AK036052; POT1b: XM_355022) and appeared ubiquitously expressed based on RT-PCR (Figure 1C) . The embryonic expression pattern of POT1a was examined using mice derived from a gene-trap ES cell line containing a b-galactosidase-neo (GEO) fusion gene inserted after the 8 th coding exon in the POT1a locus (POT1a 8GEO ; Figure S1D and see below). Heterozygous POT1a 8GEO/+ E13.5 embryos had b-galactosidase activity in the developing tissues ( Figure 1D ), indicating (near) ubiquitous expression during embryonic development.
Both POT1 proteins were detectable in immunoblots of extracts from mouse embryo fibroblasts (MEFs), ES cells, and NIH3T3 cells ( Figure 1E ). Two anti-sera raised against POT1a peptides detected a protein of $70 kDa apparent MW whose abundance was significantly reduced by shRNAs specific to POT1a. Similarly, two anti-sera raised to POT1b peptides reacted with a protein of $75 kDa apparent MW, that was identified as POT1b based on shRNA knockdown. Immunoblots and immunoprecipitation experiments indicated that the POT1a and POT1b antibodies were specific to the respective POT1 proteins ( Figure 1E and data not shown). Semiquantitative immunoblotting experiments using recombinant proteins as a standard suggested that POT1a and POT1b are expressed at similar levels ( Figure S1E ).
Indirect immunofluorescence (IF) for POT1a and POT1b revealed the punctuate nuclear pattern typical of telomeres and many of the POT1 sites coincided with TRF1 signals ( Figure 1F ). Telomeric localization was also observed for myc-tagged POT1a and POT1b (see below, Figure S3B ). Furthermore, chromatin immunoprecipitation (ChIP) with POT1a and POT1b antibodies recovered approximately the same amount of telomeric DNA but no chromosome-internal sequences, confirming that both proteins are specifically associated with telomeres ( Figures 1G and S1F, and data not shown). RNAi-mediated partial ($70%) depletion of POT1a or POT1b demonstrated the specificity of the antibodies used in these experiments (Figures 1G and S1F Figures 1C and 2E ), suggesting that POT1a and POT1b are not redundant. We therefore generated mice carrying targeted alleles allowing conditional deletion of the third coding exon of POT1a, POT1b, or both. Analogous strategies were used for the POT1a and POT1b loci ( Figures 2A and S2A) ; a detailed rationale for the targeting strategy is given in the Supplemental Data. The targeting construct introduced an FRTflanked STOP cassette (Jackson et al., 2001 ) after the second coding exon, interrupting the first OB-fold of the DNA binding domain ( Figure S1B ). Cells heterozygous for the STOP allele showed $50% less POT1a (or POT1b) protein (Figures 2E and 2G) , consistent with previous data on the STOP cassette (Jackson et al., 2001 ). Intercrosses of POT1a STOP/+ mice confirmed that POT1a deficiency is incompatible with mouse development ( Figure 2C ). However, POT1b STOP/STOP mice appeared healthy and fertile ( Figures 2C and 2D ). MEFs isolated from POT1b STOP/STOP embryos lacked POT1b ( Figure 2E ), and ChIP confirmed that POT1b was not present at telomeres whereas POT1a, TRF1, and TRF2 remained bound ( Figure 2F ). The targeting strategy was such that floxed alleles of POT1a and POT1b could be generated allowing the isolation of MEFs from which the third protein coding exon (referred to as exon 3) of either gene could be deleted with Cre recombinase. Multiple independent POT1a 
Figure 2. Conditional Deletion of POT1a and POT1b
(A) Targeting strategy for POT1a. Coding exons 1-5 of the POT1a genomic locus (chromosome 6), the targeting construct, and the POT1a alleles generated are shown. Yellow, probes used for genotyping (see Figure S2B ); green boxes, FRT sites; blue, LoxP sites; SA, splice acceptor.
POT1b protein (Figures 2E, 2G, S2C, and S2D) . Upon Cremediated deletion of either POT1 gene, the other POT1 paralog, TRF1, TRF2, and Rap1 remained associated with telomeres (see Figures 3 and 5 below and data not shown).
Redundant Roles for POT1a and POT1b in Cell Proliferation
Cre-mediated deletion of either POT1a or POT1b from SV40-LT immortalized MEFs did not lead to a growth arrest ( Figure 2H and data not shown). Both cell types continued to proliferate with unaltered cellular morphology although POT1a-deficient cells grew slightly slower than the controls. Similarly, deletion of POT1a from primary MEFs did not result in a growth arrest (data not shown); POT1b deficiency is tolerated in the context of the whole animal, indicating that POT1b is also not required for proliferation of nontransformed cells. In contrast, simultaneous Cre-mediated deletion of POT1a and POT1b from POT1a STOP/FLOX POT1b STOP/FLOX MEFs resulted in a rapid proliferative arrest ( Figure 2H ). These double-knockout (DKO) cells appeared to undergo senescence, as deduced from their enlarged and flattened morphology and their expression of SA-b-galactosidase (Figure 2I) . The cultures were eventually overtaken by the small fraction of cells in which the Cre-mediated deletion of POT1a and/or POT1b was incomplete ( Figure 2H and data not shown), hampering long-term analysis of DKO cells. POT1a STOP/FLOX POT1b STOP/FLOX MEFs, which contain half the normal level of POT1a and POT1b, showed no growth defect (Figures 2H and 2I) , nor did NIH3T3 cells in which POT1a and POT1b were simultaneously knocked down to $30% with shRNA (data not shown). Thus, immortalized cells can proliferate normally without either POT1a or POT1b or when the total POT1 level is lowered 2-to 3-fold but not in the complete absence of both POT1a and POT1b.
Repression of the Telomere DNA Damage Signal by POT1a and POT1b
The role of POT1a and POT1b in the repression of the DNA damage signal at telomeres was assayed based on the formation of telomere dysfunction-induced foci (TIFs) , which are cytological foci of DNA damage response factors, such as 53BP1 and g-H2AX, at chromosome ends. When both POT1a and POT1b were deleted, 70%-80% of the nuclei contained gÀH2AX and 53BP1 foci at most of the telomeres ( Figures 3A-3C ), indicating that the majority of chromosome ends had lost protection. Cells lacking only POT1b or cells heterozygous for POT1a and POT1b did not show this phenotype (Figures 3A , 3C, and S3A). A TIF response was also observed upon deletion of POT1a alone but the phenotype was limited to $30% of the cells ( Figures 3A and 3C ), indicating that POT1b contributed to the protection of telomeres. The data suggest that POT1a is sufficient to repress DNA damage signaling at telomeres even when POT1b is absent. However, POT1b contributes to telomere protection and a complete telomere DNA damage response is only observed when both proteins are removed from the telomeres. DKO cells retained TRF2 and its interacting factor Rap1 at their telomeres ( Figure 3D ). Inspection of large numbers of nuclei before and after introduction of Cre showed no obvious change in the IF patterns and intensity of TRF2 and Rap1. In addition, there was widespread colocalization of TRF2/Rap1 signals with g-H2AX in the DKO cells ( Figure 3D ). Thus, while TRF2 contributes to the recruitment of POT1 (Loayza and de Lange, 2003) , POT1a/b are not needed for the accumulation of TRF2 and Rap1 at telomeres. Furthermore, the results indicate that telomeres lacking POT1a/b have lost the ability to prevent activation of a DNA damage signal, even though TRF2 is still present.
Whereas both POT1a and POT1b contribute to the repression of the DNA damage response at telomeres, the data suggested that POT1a and POT1b are not interchangeable in terms of this function. In order to further explore the possibility that POT1a and POT1b differ in their ability to repress the telomere DNA damage response, we monitored the ability of overexpressed myc-tagged POT1a and POT1b to repress the formation of TIFs in POT1a À/À cells. Both proteins were overexpressed and localized to telomeres (Figures 3F and S3B) but differed in their ability to protect the telomeres. Overexpression of POT1a diminished the frequency of TIF positive cells by 10-fold, whereas overexpression of POT1b had only a minor effect ( Figure 3E ). These data point to a functional difference between POT1a and POT1b and argue against the possibility that the distinct phenotypes of POT1a and POT1b deletion are due to slight differences in the level of expression of the two genes.
Infrequent Chromosome-End Fusions in DKO Cells
Although many metaphases from the DKO cells showed no aberrations ( Figure 4A , panel I), approximately 60% of the metaphases contained one or a few aberrant chromosomes ( Figures 4A and 4B) . Metaphase spreads in which telomeres were detected using FISH revealed the occurrence of chromosome-type fusions with telomeric DNA at the fusion site ( Figure 4A , panels II-VI). These fusions affected $2% of the chromosomes, which is 30-fold more frequent than in control cells ( Figure 4B ). The increase in fusions in DKO cells was significant and depended on the introduction of Cre ( Figure 4B ). However, the phenotype is much less pronounced than the nearly complete fusion phenotype of cells lacking TRF2 in which each chromosome undergoes one or two fusion events (Celli and de Lange, 2005) . Furthermore, whereas TRF2 null cells have long trains of fused chromosomes, fusions of more than two chromosomes were rare in POT1 DKO cells ( Figure 4A , panels II, III, and VI). The chromosometype fusions occurred on both the short and long arm and in some cases clearly involved two different chromosomes (e.g., Figure 4A , panel IV). The fusions of two chromosomes always involved both chromatids, suggesting that most fusions occurred before DNA replication. In addition to chromosome-type telomere fusions, DKO cells contained a significant number of chromosome fusions without detectable telomeric DNA at the fusion site ( Figures 4A, panel IX, and 4B ), which could be a consequence of breakage-fusion-bridge cycles. Consistent with this possibility, anaphase bridges were observed and occasionally, chromatin bridges containing telomeric signals persisted after reformation of the nuclear envelope (Figure 4A , panel X). DKO cells also contained a few complex chromosomal rearrangements as well as chromosomes with multiple TTAGGG repeat FISH signals separated by large segments of nontelomeric DNA ( Figure 4A , panel IX). The origin of these rare abnormalities is not clear.
POT1 DKO cells appeared to have an unusual propensity to fuse or associate sister telomeres (Figures 4A, panels VII and VIII, and 4B). Although sister telomere fusions have been observed in cells lacking TRF2 (Smogorzewska et al., 2002) , they are rare and the vast majority of fusions involve nonsister telomeres (Bailey et al., 2001) . In order to distinguish sister telomere fusion from spurious juxtaposition, we only analyzed the q arm telomeres of chromosomes with clearly separated long arms. These long-arm sister telomeres of DKO cells showed a rate of sister fusion of $1%-2% of the chromosomes per cell division which is comparable to the rate of nonsister fusions.
Each of the chromosomal abnormalities observed in DKO cells were also present in POT1a-deficient cells but at significantly reduced frequency ( Figure 4B ). In contrast, POT1b-deficient cells showed no increase in telomere fusions or other chromosomal abnormalities ( Figure 4B) . Thus, POT1a appears to be sufficient for the protection of telomeres from inappropriate fusion and in its absence POT1b can partially, but not fully compensate for this function. However, the telomere fusion phenotype of DKO cells is minor compared to the phenotype of TRF2 À/À cells, indicating POT1 function is largely dispensable for the repression of NHEJ at telomeres.
Endoreduplication with Formation of Diplochromosomes
POT1a/b DKO cells displayed extensive endoreduplication (Figures 5 and S4) . As a result, some of the DKO interphase nuclei had an increased size and contained supernumerary telomeric signals (see for example Figure 5A ). In these nuclei, the telomeres tended to cluster around regions of more intense DAPI staining, which is expected since half of the mouse telomeres abut the centromeric heterochromatin. Metaphase spreads revealed a high frequency ($17%) of endoreduplicated karyotypes in which all chromosomes were present as diplo-or quadruplochromosomes ( Figures 5B and S4B) . Endoreduplication with formation of diplochromosomes is rare in immortalized control MEFs (%3% of metaphases; Figures S4A  and S4B ). FACS analysis showed that POT1a/b DKO induced an increase in cells with 8N and 16N DNA content ( Figures 5C and 5D ), consistent with one and two rounds of endoreduplication, respectively.
The repression of endoreduplication by POT1 proteins followed the pattern seen for repression of the DNA damage signal and (rare) telomere fusions. POT1a-deficient cells exhibited endoreduplication with formation of diplochromosomes in approximately 17% of the metaphase spreads ( Figure S4B ). However, FACS analysis indicated that their extent of endoreduplication was somewhat less than the DKO cells and metaphases with quadruplochromosomes were not observed ( Figure S4A and data not shown). FACS analysis and inspection of metaphase spreads showed that endoreduplication was not induced in POT1b-deficient cells ( Figures S4A and S4B) . Thus, also with regard to endoreduplication, POT1a is primarily responsible for repression of this phenotype. The mechanism by which loss of POT1 function induces endoreduplication is not known. Chromosome-end fusions are not a likely culprit since they are thought to impede the progression of mitosis after resolution of the centromeric cohesin and hence do not explain the occurrence of diplochromosomes which retain cohesion at the centromeres.
POT1b Controls Telomerase-Independent Processing of the Telomere Terminus
The structure of the telomeres in cells lacking POT1a and/ or POT1b was examined by genomic blotting of telomeric restriction fragments (Figures 6 and S5 ). Although each mouse embryo has a different pattern of telomeric restriction fragments, the size of the bulk telomeres can be assessed when the DNA is fractionated on CHEF gels. This analysis indicated that deletion of POT1a or POT1b did not result in a rapid loss or elongation of telomeric DNA. Furthermore, the size of the telomeric fragments of second-generation POT1b-deficient mice was unaltered (Figure 6C ). In addition, DKO cells had telomeres in a normal size range, consistent with the retention of the telomeric FISH signals in interphase cells and metaphase spreads (Figures 3-5) . The status of the telomere terminus was examined by quantitative analysis of the 3 0 telomeric overhang. The single-stranded telomeric DNA was detected in native DNA gels using a single-stranded [CCCTAA]4 probe. After quantification of the signal, the DNA was denatured in situ and the total amount of telomeric DNA was determined in the same lane by rehybridization with the [CCCTAA]4 probe. The ratios of single-stranded to total telomeric DNA signals were compared between samples in order to evaluate changes in the single-stranded TTAGGG repeat DNA. The relative amount of single-stranded TTAGGG repeats was not altered upon deletion of POT1a ( Figures  6A, 6B , and S5). In contrast, loss of POT1b resulted in increased single-stranded telomeric DNA signals ( Figures  6A and 6B ). The increased signal was derived from a 3 0 overhang since it was sensitive to the E. coli 3 0 exonuclease ExoI ( Figure S5A ). POT1b STOP/STOP mice showed a 7-to 11-fold increase in the overhang signal in liver, kidney, and spleen, and this phenotype was stable over two generations ( Figure 6C and data not shown). It appeared that the overhangs in POT1b-deficient MEFs gradually increased with proliferation (data not shown), consistent with the greater amount of ss TTAGGG DNA in vivo. Cells lacking both POT1a and POT1b had a similar overhang extension phenotype as POT1b-deficient cells (Figures 6A , 6B, and S5). Due to the rapid arrest of the DKO cells, we could not determine whether POT1a loss exacerbates the phenotype. The DKO cells contained a class of overhang-bearing telomeric restriction fragments that migrated throughout the lane, suggesting an unusual DNA structure. The smearing of the signal into the higher MW fractions and beyond was not prominent when the total telomeric DNA was examined after denaturation of the DNA, indicating that these molecules were relatively rare and only detectable due to their longer overhangs. In order to establish whether the elongation of the overhangs was a specific phenotype of loss of POT1b, we determined to what extent exogenously expressed POT1a and POT1b were able to suppress this phenotype of POT1b-deficient cells. As shown above ( Figures 3F and  S3B) , both proteins were overexpressed and localized to telomeres. POT1b was able to reestablish a normal telomere terminus structure, whereas POT1a overexpression had no effect ( Figure 6D ). We conclude that the control of the telomeric overhang is primarily dependent on POT1b.
We next asked whether the extended telomeric overhangs are due to deregulation of telomerase at the telomere terminus. POT1b mutant mice were crossed with mice that lack telomerase due to deletion of the mTERC gene encoding the RNA component of telomerase (Blasco et al., 1997) . MEFs that lacked mTERC and had a conditional POT1b allele were established and immortalized with SV40-LT. Cre-mediated POT1b deletion resulted in comparable extension of the 3 0 overhang in both mTERC +/À and mTERC À/À cells, indicating that telomerase is not responsible for the elongation of the 3 0 ends ( Figure 6E ). We conclude that POT1b maintains the integrity of the telomere terminus by regulating a telomeraseindependent processing step.
DISCUSSION
Our results reveal an unexpected difference between human and rodent shelterin. Human shelterin contains a single POT1 protein, whereas the mouse version of this complex is more elaborate, containing roughly equal levels of two functionally distinct POT1 proteins, POT1a and POT1b. Since their duplication, the two mouse POT1 paralogs diverged to the extent that full protection of the telomeres requires both factors. For example, POT1a is necessary to fully repress a DNA damage signal at telomeres. POT1b can partially compensate for the loss of POT1a, but its ability to repress the telomere damage response is incomplete. Conversely, POT1b has a specific role in regulating the structure of the telomere terminus, leading to deregulation of the telomeric overhang in POT1b-deficient cells, despite the presence of POT1a. Thus, while POT1a and POT1b are relatively recent additions to shelterin, they have distinct functions and are both required for the protection of mouse telomeres. It is possible that the single human POT1 protein combines the functions of mouse POT1a and POT1b although attempts at complementation with human POT1 have so far failed (D.H. and T.d.L., unpublished data).
Within the context of fundamental aspects of mammalian chromosome biology, the rodent duplication of the POT1 gene and functional divergence of the two resulting POT1 paralogs is unprecedented. No comparable case has emerged from comparisons of human and mouse genes involved in kinetochore function, origin firing and regulation, or DNA damage detection and repair. Other genes relevant to telomere biology, such as those for telomerase components and the genes for the other shelterin proteins are present at single copy in all sequenced mammalian genomes. Previous findings revealed substantial differences between the telomeric proteins in budding yeast on the one hand and fission yeast and mammals on the other. The current results provide evidence for much more recent changes in the telomeric complex and attest to the rapid evolution of the telomere/telomerase system.
POT1a and POT1b
Play a Key Role in Repressing the Telomere DNA Damage Response POT1a/b DKO cells lack the ability to distinguish telomeres from sites of DNA damage. Most of their telomeres become associated with DNA damage response factors and the cells arrest, most likely due to a permanent DNA damage signal. The severity of this telomere damage phenotype is similar to that of mouse cells lacking TRF2 (Celli and de Lange, 2005 ). Yet, TRF2 is not removed from telomeres lacking POT1a/b. This finding raises the possibility that the POT1 proteins contribute to the mechanism by which TRF2 prevents DNA damage signaling at chromosome ends (Figure 7) . The recruitment of POT1 to telomeres is thought to depend on both TRF1 and TRF2, which bring the POT1 interacting factor TPP1 to the telomere (reviewed in de Lange, 2005) . While these interactions have not been verified in mouse cells, the residues required for TPP1 binding are conserved in mouse POT1a and POT1b. Thus, the DNA damage phenotype of TRF2 null mouse cells could be solely due to insufficient POT1 at the chromosome ends but other possibilities have not been excluded.
The Repression of NHEJ at Telomeres
When TRF2 is deleted, most telomeres are processed by the NHEJ pathway, leading to nearly complete fusion of the genome (Celli and de Lange, 2005) . In contrast, telomeres lacking POT1a and POT1b remain largely protected from this type of inappropriate repair. This result indicates that POT1 is not required for the repression of most NHEJ events and is consistent with NHEJ being blocked by the formation of t-loops, a process ascribed to TRF2 (Figure 7 ). However, a small fraction of the chromosome ends in POT1 DKO cells do undergo fusions, pointing to an important, albeit minor role of POT1a/b in the repression of NHEJ. One possibility is that POT1a/b aids in repression of NHEJ when t-loops are resolved (Figure 7 ), for instance when the replication fork progresses through the strandinvasion site. We imagine that the presence of POT1a/b on the single-stranded overhang might interfere with efficient loading of Ku70/80 or prevent cleavage of the overhang, thereby thwarting NHEJ.
POT1b Blocks Formation of Excessive
Single-Stranded Telomeric DNA The maintenance of the normal structure of the telomere terminus is dependent on POT1b. In its absence, cells contain up to 10-fold more single-stranded TTAGGG repeat DNA. Although we do not know whether the increase in overhang sequences affects all telomere equally, if it does, the overhangs may be as long as 2 kb. The total amount of single-stranded TTAGGG repeat DNA could be in excess of 200 kb in the nuclei of liver cells lacking POT1b. This type of alteration has not previously been observed in mammalian cells, nor does it occur in fission yeast lacking POT1 (Baumann and Cech, 2001) . However, in the budding yeast cdc13-1 mutant, inactivation of the POT1-like Cdc13 protein results in excessively long 3 0 overhangs (Garvik et al., 1995) . The long single-stranded regions are thought to activate the MEC1/RAD9 pathway, explaining the lethality of cdc13-1. In contrast, the excess single-stranded DNA of POT1b-deficient cells did not appear to activate a DNA damage checkpoint and mice lacking POT1b are healthy and fertile. In the cdc13-1 mutant, the long 3 0 overhangs are generated by exonucleolytic degradation of the C-rich telomeric DNA strand in an Exo1-and Rad24-dependent manner (Zubko et al., 2004) . A similar mechanism may well be responsible for the excess single-stranded telomeric DNA in POT1b-deficient cells (Figure 7) . In this regard, RNAi-mediated knockdown of human POT1 results in an altered sequence at the 5 0 end of the C-rich telomeric repeat strand which could also be a consequence diminished control of a 5 0 exonuclease (Hockemeyer et al., 2005) .
More Than One Pathway for Telomere Protection
The results argue against models in which all telomere protection is simply based on the loading of one protective protein. Rather, different shelterin components have distinct as well as overlapping roles in preventing inappropriate DNA damage signaling and repair at chromosome ends ( Figure 7 ). POT1b is required for the maintenance of a normal telomere terminus structure. Neither POT1a nor TRF2 have the ability to control this pathway when POT1b is absent. On the other hand, complete repression of DNA damage signaling at telomeres requires POT1a. POT1b is insufficient to fully protect telomeres in this regard although its contribution to this pathway is inferred from the more severe telomere damage phenotype of the DKO cells. TRF2 is also required for repression of the Mouse shelterin is depicted as a complex of TRF1, TRF2, Rap1, TIN2, TPP1, and POT1a and POT1b. The details of the protein interactions are in part based on information from human shelterin. It is not known whether POT1a and POT1b are present in the same complex or in two different versions of shelterin. Repression of the DNA damage signal at telomeres requires TRF2, POT1a and POT1b. Repression of NHEJ is largely independent of POT1a and -b but requires TRF2. NHEJ is proposed to be repressed through sequestration of the telomere terminus in the t-loop. POT1a and POT1b are proposed to repress NHEJ at telomeres that are not in the t-loop configuration. POT1b is required to prevent generation of inappropriately long telomeric 3 0 overhangs.
telomere DNA damage signal although it remains to be determined whether its function is independent of POT1a/b. In contrast, the protection of telomeres from NHEJ involves a pathway that requires TRF2 but is largely independent of the POT1 paralogs. The simplest interpretation of these findings is that telomere protection is achieved through at least three distinct pathways: POT1b-dependent control of the terminus structure; repression of a DNA damage signal involving TRF2, POT1a, and POT1b; and TRF2-dependent repression of NHEJ. In addition, telomeres are protected from inappropriate homologous recombination, but the genetic requirements for this aspect of telomere function remain largely undefined (Wang et al., 2004) .
Implications
The unusual divergence of mouse shelterin has implications for the use of mouse models for human telomererelated disease states. Deletion of essential telomerase components has allowed the establishment of mice with shortening telomeres that ultimately become dysfunctional and mimic aspects of telomere dysfunction in human cells (Blasco et al., 1997; Erdmann et al., 2004) . These systems have been used to study the impact of telomere dysfunction on tumorigenesis, revealing that telomere dysfunction can limit tumor progression in some settings while promoting genome instability in others (Artandi et al., 2000; Greenberg et al., 1999; Maser and DePinho, 2002) . Furthermore, the telomerase-knockout mouse has been used to model aspects of the human telomerase disease, dyskeratosis congenita (Armanios et al., 2005) , and to study interactions between shortening telomeres and genetic defects such as Ataxia Telangiectasia and Werner syndrome (Laud et al., 2005; Qi et al., 2003; Wong et al., 2003) . Similarly, we have used a mouse TRF2-knockout model to dissect the signaling pathway activated by dysfunctional telomeres (Celli and de Lange, 2005) . Interpretation of these and other experiments rely on the assumption that mouse and human telomeres are structurally and functionally identical. The finding of an altered shelterin at mouse telomeres challenges this assumption. As more refined mouse models are developed, the potential pitfalls of working within the context of a different shelterin complex will have to be taken into account and the principles gleaned from work on mouse telomeres will require detailed verification in human cells.
EXPERIMENTAL PROCEDURES
Mice and MEFs with Altered POT1 Alleles POT1a 8GEO/+ mice were generated from the Baygenomics clone RRA096. Gene-targeting constructs for POT1a and POT1b were generated using appropriate restriction fragments from BAC clones subcloned into pSL301 (Invitrogen) next to a DTA cassette. A STOP cassette (Jackson et al., 2001 ) flanked by FRT sites was introduced. The constructs also contained a puromycin resistance gene next to the STOP cassette and a neomycin resistance gene flanked by LoxP sites. A third LoxP site was introduced by inserting an oligonucleotide that also introduced a BamHI restriction site used for the analysis of targeting in ES cells. Targeted ES cell clones were injected into C57BL/6J blastocysts, and chimeric founders were crossed to C57BL/6J females. Mice were kept in a mixed 129/ C57BL/6J background. FLOXed alleles were generated by removing the STOP cassette using a FLPe deleter mouse stain (Jackson Labs). mTERC-deficient mice (Blasco et al., 1997) Primary MEFs from E13.5 embryos were immortalized at passage 2 with pBabeSV40LT (a gift from G. Hannon). Cre was introduced using Hit&Run Cre-GFP (Silver and Livingston, 2001 ), pWZL-Cre, or Ad5 CMV Cre (Resource Center, The University of Iowa, Iowa City, IA) and deletion was monitored by PCR. POT1 proteins were stably knocked down in NIH3T3 cells using pSicoR-GFP vector technology (Ventura et al., 2004 ; a gift from T. Jacks).
ChIP, IF, and Immunoblotting ChIPs were performed as described previously (Loayza and de Lange, 2003; Ye et al., 2004) with the difference that a probe for the BamHI repeat element (Fanning, 1983 ) was used to detect bulk genomic DNA. Immunoblots and IF for POT1a and POT1b were performed using the protocols described previously (Hockemeyer et al., 2005; Loayza and de Lange, 2003) . POT1a antibodies 1220 and 1221 were raised in rabbits against a POT1a peptide representing amino acids 395-421. POT1b antibodies 1222 and 1223 were raised against a POT1b peptide representing amino acids 285-307. IF for g-H2AX was performed using a mouse aÀgÀH2AX antibody (Upstate Biotechnology, Lake Placid, NY); 53BP1 FISH/IF staining was performed using a polyclonal rabbit anti human 53BP1 antibody, (Novus, [NB 100-304]) using the protocol developed by Sedivy and colleagues (Herbig et al., 2004) . POT1a IF was performed using a mouse antibody against GSTPOT1a fusion protein. POT1b IF was performed using a mouse antibody against GST-fused to POT1b (aa 1-342). TRF1 IF was performed with Ab 644 (Karlseder et al., 2003) .
Analysis of Telomeric DNA
Mouse telomeric DNA was analyzed on CHEF gels using previously described protocols (Celli and de Lange, 2005) . FISH for telomeric DNA was preformed as described (Celli and de Lange, 2005) 
